PNC Financial Services Group’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$220 Sell
94
-30
-24% -$74 ﹤0.01% 5225
2026
Q2
$161 Sell
124
-113
-48% -$164 ﹤0.01% 5118
2026
Q1
$344 Buy
237
+232
+4,640% +$368 ﹤0.01% 4980
2025
Q4
$7 Hold
5
– – ﹤0.01% 5145
2025
Q3
$14 Buy
+5
New +$18 ﹤0.01% 5066
2022
Q3
– Sell
-981
Closed -$3K – 4608
2022
Q2
$3K Hold
981
– – ﹤0.01% 4121
2022
Q1
$3K Hold
981
– – ﹤0.01% 4115
2021
Q4
$4K Hold
981
– – ﹤0.01% 4013
2021
Q3
$6K Hold
981
– – ﹤0.01% 3864
2021
Q2
$16K Hold
981
– – ﹤0.01% 3515
2021
Q1
$12K Sell
981
-48
-5% -$736 ﹤0.01% 3561
2020
Q4
$11K Hold
1,029
– – ﹤0.01% 3518
2020
Q3
$5K Hold
1,029
– – ﹤0.01% 3669
2020
Q2
$2K Buy
+1,029
New +$2.11K ﹤0.01% 3769

Other funds holding STIM

PNC Financial Services Group's STIM Position: Q3 2026 in Review

PNC Financial Services Group reduced its Neuronetics (STIM) stake by 24% in Q3 2026, selling an estimated $74 and leaving 94 shares worth $220. The position accounts for ﹤0.01% of the portfolio, ranked #5225.

PNC Financial Services Group first reported a position in STIM in Q2 2020 and has held it in 14 quarters since. The position peaked at $16K in Q2 2021. 96 funds tracked by Wall St. Rank hold STIM as of Q3 2026.

  • PNC Financial Services Group held 94 shares of Neuronetics worth $220 as of Q3 2026.
  • PNC Financial Services Group sold 30 Neuronetics shares in Q3 2026, an estimated $74.
  • Neuronetics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #5225 holding.
  • PNC Financial Services Group first reported a position in Neuronetics in Q2 2020 and has held it in 14 quarters since.
  • PNC Financial Services Group's Neuronetics position peaked at $16K in Q2 2021.
  • 96 funds tracked by Wall St. Rank held Neuronetics as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.